This study investigates metastatic pancreatic cancer. Participants will receive a combination of treatments to understand how well they work together.
The study evaluates the safety and tolerability of the combined treatment approach. It also looks at how participants respond to these treatments over time.
- Who can participate: Adults 18 years and older with metastatic pancreatic cancer may join. Participants should not have had prior treatment for stage IV disease and must meet specific health criteria.
- Study details: Participants will receive an investigational treatment.